Previous studies have confirmed that NLRC3 prevents colorectal cancer growth by suppressing the PI3K-mTOR signaling pathway and that it may suppress HCC progression by promoting CD8+ T-cell infiltration7,8. This evidence concerns the gene CD8A and hepatocellular carcinoma.